Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $29.2 million.

  • Rallybio's Cash from Investing Activities rose 3162.35% to $29.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year decrease of 1963.29%. This contributed to the annual value of $33.5 million for FY2024, which is 2109.34% up from last year.
  • Latest data reveals that Rallybio reported Cash from Investing Activities of $29.2 million as of Q3 2025, which was up 3162.35% from $3.0 million recorded in Q2 2025.
  • Rallybio's Cash from Investing Activities' 5-year high stood at $29.2 million during Q3 2025, with a 5-year trough of -$1.6 million in Q4 2024.
  • In the last 3 years, Rallybio's Cash from Investing Activities had a median value of $6.2 million in 2023 and averaged $9.5 million.
  • Within the past 5 years, the most significant YoY rise in Rallybio's Cash from Investing Activities was 62328.99% (2024), while the steepest drop was 10930.27% (2024).
  • Quarter analysis of 3 years shows Rallybio's Cash from Investing Activities stood at $16.9 million in 2023, then plummeted by 109.3% to -$1.6 million in 2024, then skyrocketed by 1958.04% to $29.2 million in 2025.
  • Its Cash from Investing Activities stands at $29.2 million for Q3 2025, versus $3.0 million for Q2 2025 and $11.1 million for Q1 2025.